SEC Form 4 research
| Issuer | Eloxx Pharmaceuticals, Inc. |
|---|---|
| Tickers | ELOX, SVON, SNTI, SVOND, SNT |
| Reporting owners | 61 |
| Officers and directors | 16 |
| Last public filing | 2026-10-21 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-21 | 2026-10-19 | Germano Geno J | A | 13,587 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.